Concepedia
Statistics
Publications
13
Citations
583
H-Index
12
Active since
1994
Affiliations
Rotterdam University of Applied Sciences(Current)
Slotervaartziekenhuis
The Netherlands Cancer Institute
Erasmus MC Cancer Institute
Utrecht University
JHM Schellens is an author at Rotterdam University of Applied Sciences specializing in pharmacology, medicine, and chemotherapy.
Publications per year
1994–2012
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours
JHM Schellens, Jun Ma, A.S.T. Planting et al. · British Journal of Cancer · 1996 · 146 citations · Full text
Medicine, Oncology, Toxicology +14
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor
JHM Schellens, G.J. Creemers, Hilde Rosing et al. · British Journal of Cancer · 1996 · 130 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +11
Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line
Jun Ma, Marc Maliepaard, Kees Nooter et al. · British Journal of Cancer · 1998 · 62 citations
Medicine, Oncology, Pharmacology +16
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration
CJH Gerrits, G.J. Creemers, JHM Schellens et al. · British Journal of Cancer · 1996 · 45 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +10
Pharmacokinetic-dynamic relationship of cisplatin in vitro: simulation of an i.v. bolus and 3 h and 20 h infusion
Jun Ma, Jaap Verweij, H. J. Kolker et al. · British Journal of Cancer · 1994 · 34 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +12
1–5 of 13